Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


Inhibitor of EGFR and ErbB-2
ENZ-CHM177-0010 10 mg 57.00 USD
Do you need bulk/larger quantities?
Lapatinib is an ATP-competitive epidermal growth factor receptor (EGFR) and HER2/neu (ErbB-2) dual tyrosine kinase inhibitor, with IC50 values of 10.8 and 9.2 nM respectively. It is an orally active drug for treatment of breast cancer and other solid tumors.

Product Specification

Alternative Name:GW 572016, GSK 572016
Purity:≥99% (HPLC)
Identity:Determined by EM-MS, NMR
Appearance:Yellow powder.
Solubility:Soluble in DMSO (100 mg/ml) or ethanol (1mg/ml).
Short Term Storage:+4°C
Long Term Storage:-20°C
ENZ-CHM177 structure
Please mouse over
ENZ-CHM177 structure

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2018 Enzo Life Sciences, Inc.,